These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2910921)

  • 1. Reduction of dietary phosphorus absorption by phosphorus binders. A theoretical, in vitro, and in vivo study.
    Sheikh MS; Maguire JA; Emmett M; Santa Ana CA; Nicar MJ; Schiller LR; Fordtran JS
    J Clin Invest; 1989 Jan; 83(1):66-73. PubMed ID: 2910921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium acetate, an effective phosphorus binder in patients with renal failure.
    Mai ML; Emmett M; Sheikh MS; Santa Ana CA; Schiller L; Fordtran JS
    Kidney Int; 1989 Oct; 36(4):690-5. PubMed ID: 2811066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of pH on in vitro disintegration of phosphate binders.
    Stamatakis MK; Alderman JM; Meyer-Stout PJ
    Am J Kidney Dis; 1998 Nov; 32(5):808-12. PubMed ID: 9820451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal absorption of calcium from milk and calcium salts.
    Sheikh MS; Santa Ana CA; Nicar MJ; Schiller LR; Fordtran JS
    N Engl J Med; 1987 Aug; 317(9):532-6. PubMed ID: 3614304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of the phosphate binder, ferric citrate hydrate (JTT-751), about phosphorus absorption-reducing effect in normal rats.
    Matsuo A; Iida A; Tanimoto M; Matsushita M; Miyamoto K
    Ren Fail; 2014 Sep; 36(8):1291-7. PubMed ID: 24975675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of clinically useful phosphorus binders for patients with chronic kidney failure.
    Emmett M
    Kidney Int Suppl; 2004 Sep; (90):S25-32. PubMed ID: 15296504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients.
    Janssen MJ; van der Kuy A; ter Wee PM; van Boven WP
    Clin Nephrol; 1996 Feb; 45(2):111-9. PubMed ID: 8846523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the time of administration of calcium acetate on phosphorus binding.
    Schiller LR; Santa Ana CA; Sheikh MS; Emmett M; Fordtran JS
    N Engl J Med; 1989 Apr; 320(17):1110-3. PubMed ID: 2710173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The absorption of dietary phosphorus and calcium in hemodialysis patients.
    Ramirez JA; Emmett M; White MG; Fathi N; Santa Ana CA; Morawski SG; Fordtran JS
    Kidney Int; 1986 Nov; 30(5):753-9. PubMed ID: 3784305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of calcium acetate or calcium citrate on intestinal aluminum absorption.
    Nolan CR; Califano JR; Butzin CA
    Kidney Int; 1990 Nov; 38(5):937-41. PubMed ID: 2266679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose dependency of calcium absorption: a comparison of calcium carbonate and calcium citrate.
    Harvey JA; Zobitz MM; Pak CY
    J Bone Miner Res; 1988 Jun; 3(3):253-8. PubMed ID: 3213620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of calcium carbonate and calcium citrate on the absorption of zinc in healthy female subjects.
    Argiratos V; Samman S
    Eur J Clin Nutr; 1994 Mar; 48(3):198-204. PubMed ID: 8194505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium beta-hydroxy-beta-methylbutyrate. 1. Potential role as a phosphate binder in uremia: in vitro study.
    Sousa MF; Abumrad NN; Martins C; Nissen S; Riella MC
    Nephron; 1996; 72(3):391-4. PubMed ID: 8852485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium acetate versus calcium carbonate as phosphorus binders in patients on chronic haemodialysis: a controlled study.
    Ring T; Nielsen C; Andersen SP; Behrens JK; Sodemann B; Kornerup HJ
    Nephrol Dial Transplant; 1993; 8(4):341-6. PubMed ID: 8390009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium absorption and achlorhydria.
    Recker RR
    N Engl J Med; 1985 Jul; 313(2):70-3. PubMed ID: 4000241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphate binders in hyperphosphatemia of chronic renal failure.
    Wasan SM; Godley PJ
    DICP; 1991 Sep; 25(9):942-5. PubMed ID: 1949972
    [No Abstract]   [Full Text] [Related]  

  • 19. Calcium bioavailability from calcium carbonate and calcium citrate.
    Nicar MJ; Pak CY
    J Clin Endocrinol Metab; 1985 Aug; 61(2):391-3. PubMed ID: 4008614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient phosphate binding using a combination of gluconolactate and carbonate calcium salts.
    Legendre JY; Cote S; Pradeau D; Hamon M; Vitzling C; Lavene D; Tarral A
    J Clin Pharm Ther; 1994 Aug; 19(4):233-8. PubMed ID: 7989401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.